glp 1 chronic kidney disease GLP-1 Receptor Agonists and Protection Chronic kidney disease in type

GI Adverse Events with GLP-1 Receptor Agonists for Weight Loss: Understanding the Risks Philip Schoenfeld, MD, MSEd, MSc (Epi) 1 and Sonali Paul, MD, MS 2 1 2 1 Chief (Emeritus), Gastroenterology Section, John D

Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation

When you eat, your intestines release GLP-1 to signal fullness to your brain, slow down digestion, and manage blood sugar

Perugino, G

[sources 14] Animal models of neurotoxicity from high-dose amphetamine exposure indicate that the occurrence of hyperpyrexia (i.e., core body temperature 40 C) is necessary for the development of amphetamine-induced neurotoxicity

Between 2017 and 2022, there were 5,713 single-substance exposure cases reported to U.S